489 Bevacizumab (BV) in combination with chemotherapy in the treatment of HER2-negative metastatic breast cancer (mBC): PFS subgroup results from two phase III studies
| Autor: | Glaspy, J., Dieras, V., Brufsky, A., Miles, D.W., Phan, S.C., O'Shaughnessy, J. |
|---|---|
| Zdroj: | In EJC Supplements 2010 8(3):202-202 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect